Lv1
84 积分 2025-10-08 加入
Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+β7+ cells in IgA nephropathy
1个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours
1个月前
已完结
Efficacy and Safety of Ravulizumab in IgA Nephropathy
1个月前
已完结
Current trial landscape of IgA nephropathy therapy
1个月前
已完结
B cell-derived exosomal miR-483-5p and its potential role in promoting kidney function loss in IgA nephropathy
1个月前
已完结
Role of the gut microbiota in the pathogenesis of IgA nephropathy
1个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Way Stations in Progress — Burgeoning Treatment Options for IgA Nephropathy
1个月前
已完结
Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis
2个月前
已完结
皖公网安备34019202002308
